233 related articles for article (PubMed ID: 31379829)
1. Activation of the DR3-TL1A Axis in Donor Mice Leads to Regulatory T Cell Expansion and Activation With Reduction in Graft-Versus-Host Disease.
Mavers M; Simonetta F; Nishikii H; Ribado JV; Maas-Bauer K; Alvarez M; Hirai T; Turkoz M; Baker J; Negrin RS
Front Immunol; 2019; 10():1624. PubMed ID: 31379829
[TBL] [Abstract][Full Text] [Related]
2. DR3 signaling modulates the function of Foxp3+ regulatory T cells and the severity of acute graft-versus-host disease.
Nishikii H; Kim BS; Yokoyama Y; Chen Y; Baker J; Pierini A; Alvarez M; Mavers M; Maas-Bauer K; Pan Y; Chiba S; Negrin RS
Blood; 2016 Dec; 128(24):2846-2858. PubMed ID: 27760760
[TBL] [Abstract][Full Text] [Related]
3. Marked in Vivo Donor Regulatory T Cell Expansion via Interleukin-2 and TL1A-Ig Stimulation Ameliorates Graft-versus-Host Disease but Preserves Graft-versus-Leukemia in Recipients after Hematopoietic Stem Cell Transplantation.
Wolf D; Barreras H; Bader CS; Copsel S; Lightbourn CO; Pfeiffer BJ; Altman NH; Podack ER; Komanduri KV; Levy RB
Biol Blood Marrow Transplant; 2017 May; 23(5):757-766. PubMed ID: 28219835
[TBL] [Abstract][Full Text] [Related]
4. Treatment with agonistic DR3 antibody results in expansion of donor Tregs and reduced graft-versus-host disease.
Kim BS; Nishikii H; Baker J; Pierini A; Schneidawind D; Pan Y; Beilhack A; Park CG; Negrin RS
Blood; 2015 Jul; 126(4):546-57. PubMed ID: 26063163
[TBL] [Abstract][Full Text] [Related]
5. BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT.
Copsel SN; Lightbourn CO; Barreras H; Lohse I; Wolf D; Bader CS; Manov J; Kale BJ; Shah D; Brothers SP; Perez VL; Komanduri KV; Wahlestedt C; Levy RB
Front Immunol; 2018; 9():3104. PubMed ID: 30733722
[TBL] [Abstract][Full Text] [Related]
6. TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation.
Meylan F; Richard AC; Siegel RM
Immunol Rev; 2011 Nov; 244(1):188-96. PubMed ID: 22017439
[TBL] [Abstract][Full Text] [Related]
7. Very Low Numbers of CD4
Copsel S; Wolf D; Kale B; Barreras H; Lightbourn CO; Bader CS; Alperstein W; Altman NH; Komanduri KV; Levy RB
Biol Blood Marrow Transplant; 2018 Sep; 24(9):1788-1794. PubMed ID: 29751114
[TBL] [Abstract][Full Text] [Related]
8. Sustained TL1A expression modulates effector and regulatory T-cell responses and drives intestinal goblet cell hyperplasia.
Taraban VY; Slebioda TJ; Willoughby JE; Buchan SL; James S; Sheth B; Smyth NR; Thomas GJ; Wang EC; Al-Shamkhani A
Mucosal Immunol; 2011 Mar; 4(2):186-96. PubMed ID: 20962771
[TBL] [Abstract][Full Text] [Related]
9. TL1A-DR3 Plasma Levels Are Predictive of HIV-1 Disease Control, and DR3 Costimulation Boosts HIV-1-Specific T Cell Responses.
Oriol-Tordera B; Olvera A; Duran-Castells C; Llano A; Mothe B; Massanella M; Dalmau J; Ganoza C; Sanchez J; Calle ML; Clotet B; Martinez-Picado J; Negredo E; Blanco J; Hartigan-O'Connor D; Brander C; Ruiz-Riol M
J Immunol; 2020 Dec; 205(12):3348-3357. PubMed ID: 33177161
[TBL] [Abstract][Full Text] [Related]
10. Death Receptor 3 Signaling Controls the Balance between Regulatory and Effector Lymphocytes in SAMP1/YitFc Mice with Crohn's Disease-Like Ileitis.
Li Z; Buttó LF; Buela KA; Jia LG; Lam M; Ward JD; Pizarro TT; Cominelli F
Front Immunol; 2018; 9():362. PubMed ID: 29545797
[TBL] [Abstract][Full Text] [Related]
11. Differential Levels of Tl1a Affect the Expansion and Function of Regulatory T Cells in Modulating Murine Colitis.
Sidhu-Varma M; Shih DQ; Targan SR
Inflamm Bowel Dis; 2016 Mar; 22(3):548-59. PubMed ID: 26818423
[TBL] [Abstract][Full Text] [Related]
12. Cloning, expression, and functional characterization of TL1A-Ig.
Khan SQ; Tsai MS; Schreiber TH; Wolf D; Deyev VV; Podack ER
J Immunol; 2013 Feb; 190(4):1540-50. PubMed ID: 23319737
[TBL] [Abstract][Full Text] [Related]
13. TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-stimulatory System of Cytokines With Diverse Functions in Gut Mucosal Immunity.
Valatas V; Kolios G; Bamias G
Front Immunol; 2019; 10():583. PubMed ID: 30972074
[TBL] [Abstract][Full Text] [Related]
14. The TNF-family ligand TL1A and its receptor DR3 promote T cell-mediated allergic immunopathology by enhancing differentiation and pathogenicity of IL-9-producing T cells.
Richard AC; Tan C; Hawley ET; Gomez-Rodriguez J; Goswami R; Yang XP; Cruz AC; Penumetcha P; Hayes ET; Pelletier M; Gabay O; Walsh M; Ferdinand JR; Keane-Myers A; Choi Y; O'Shea JJ; Al-Shamkhani A; Kaplan MH; Gery I; Siegel RM; Meylan F
J Immunol; 2015 Apr; 194(8):3567-82. PubMed ID: 25786692
[TBL] [Abstract][Full Text] [Related]
15. Death receptor 3 is essential for generating optimal protective CD4⁺ T-cell immunity against Salmonella.
Buchan SL; Taraban VY; Slebioda TJ; James S; Cunningham AF; Al-Shamkhani A
Eur J Immunol; 2012 Mar; 42(3):580-8. PubMed ID: 22259035
[TBL] [Abstract][Full Text] [Related]
16. The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases.
Meylan F; Davidson TS; Kahle E; Kinder M; Acharya K; Jankovic D; Bundoc V; Hodges M; Shevach EM; Keane-Myers A; Wang EC; Siegel RM
Immunity; 2008 Jul; 29(1):79-89. PubMed ID: 18571443
[TBL] [Abstract][Full Text] [Related]
17. The tumor necrosis factor-like cytokine 1A/death receptor 3 cytokine system in intestinal inflammation.
Bamias G; Jia LG; Cominelli F
Curr Opin Gastroenterol; 2013 Nov; 29(6):597-602. PubMed ID: 24100723
[TBL] [Abstract][Full Text] [Related]
18. Tumor Necrosis Factor-like Cytokine TL1A and Its Receptors DR3 and DcR3: Important New Factors in Mucosal Homeostasis and Inflammation.
Siakavellas SI; Bamias G
Inflamm Bowel Dis; 2015 Oct; 21(10):2441-52. PubMed ID: 26099067
[TBL] [Abstract][Full Text] [Related]
19. Host natural killer T cells induce an interleukin-4-dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host disease.
Pillai AB; George TI; Dutt S; Strober S
Blood; 2009 Apr; 113(18):4458-67. PubMed ID: 19221040
[TBL] [Abstract][Full Text] [Related]
20. Tregs expanded in vivo by TNFRSF25 agonists promote cardiac allograft survival.
Wolf D; Schreiber TH; Tryphonopoulos P; Li S; Tzakis AG; Ruiz P; Podack ER
Transplantation; 2012 Sep; 94(6):569-74. PubMed ID: 22902792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
